Large-scale genome-wide association meta-analysis of endometriosis reveals 13 novel loci and genetically-associated comorbidity with other pain conditions
Rahmioglu N., Banasik K., Christofidou P., Danning R., Galarneau G., Giri A., MacGregor S., Mortlock S., Sapkota Y., Schork A., Sobalska-Kwapis M., Stefansdottir L., Turman C., Oimari O., Adachi S., Andrews S., Arnadottir R., Burgdorf K., Campbell A., Cheuk CSK., Clementi C., Cook J., De Vivio I., DiVasta A., Dorien O., Edwards T., Fontanillas P., Fung J., Geirsson R., Girling J., Harris H., Holdsworth-Carson S., Houshdaran S., Hu-Seliger T., Jarvelin M-R., Kepka E., Kulig B., Laufer M., Law M., Low S-K., Mangino M., Marciniak B., Matalliotaki C., Matalliotakis M., Murray A., Nezhat C., Noukas M., Olsen C., Padmanabhan S., Paranjpe M., Parfitt D-E., Peters M., Polak G., Porteous D., Romanowicz H., Saare M., Shafrir A., Siewierska-Gorska A., Skarp S., Slomka M., Smith B., Smolarz B., Szaflik T., Szyllo K., Terry K., Thorleifsson G., Tomassetti C., Vanhie A., Vincent K., Vitonis A., Werge T., Chasman D., DHooghe T., Giudice L., Goulielmos G., Hapangama D., Hayward C., Horne A., Kamatani Y., Kubo M., Martikainen H., Rogers P., Saunders P., Sirota M., Spector T., Strapagiel D., Tung J., Whiteman D., Becker C., Salumets A., Magi R., Kraft P., Nyegaard M., Nyholt D., Steinthorsdottir V., Stefansson K., Velez-Edwards D., Yurttas Beim P., Missmer S., Montgomery G., Morris A., Zondervan K., DBDS Genetic Consortium None., iPSYCH-Broad Consortium None., the Celmatix Research Team None., the 23andMe Research Team None.
Endometriosis is a common complex inflammatory condition characterised by the presence of endometrium-like tissue outside the uterus, mainly in the pelvic area. It is associated with chronic pelvic pain and infertility, and its pathogenesis remains poorly understood. The disease is typically classified according to the revised American Fertility Society (rAFS) 4-stage surgical assessment system, although stage does not correlate well with symptomatology or prognosis. Previously identified genetic variants mainly are associated with stage III/IV disease, highlighting the need for further phenotype-stratified analysis that requires larger datasets. We conducted a meta-analysis of 15 genome-wide association studies (GWAS) and a replication analysis, including 58,115 cases and 733,480 controls in total, and sub-phenotype analyses of stage I/II, stage III/IV and infertility-associated endometriosis cases. This revealed 27 genetic loci associated with endometriosis at the genome-wide p-value threshold (P<5x10-8), 13 of which are novel and an additional 8 novel genes identified from gene-based association analyses. Of the 27 loci, 21 (78%) had greater effect sizes in stage III/IV disease compared to stage I/II, 1 (4%) had greater effect size in stage I/II compared to stage III/IV and 17 (63%) had greater effect sizes when restricted to infertility-associated endometriosis cases compared to overall endometriosis. These results suggest that specific variants may confer risk for different sub-types of endometriosis through distinct pathways. Analyses of genetic variants underlying different pain symptoms reported in the UK Biobank showed that 7/9 had positive significant (p<1.28x10-3) positive genetic correlations with endometriosis, suggesting a genetic basis for sensitivity to pain in general. Additional conditions with significant positive genetic correlations with endometriosis included uterine fibroids, excessive and irregular menstrual bleeding, osteoarthritis, diabetes as well as menstrual cycle length and age at menarche. These results provide a basis for fine-mapping of the causal variants at these 27 loci, and for functional follow-up to understand their contribution to endometriosis and its potential subtypes.